Retatrutide will be a new medication for diabetes, weight loss and may also show promising cardiovascular benefits
Benefits provided at no additional cost include, but are not limited to, virtual care management, behavioral health services, oncology navigation, womens health support and personalized care coordination for all individual Blue Cross PPO and BCN HMO plans
Predicting drug release kinetics from nanocarriers inside dialysis bags
This guide breaks down the science, practical application, and real-world expectations
Renal function generally improves with GLP-1 agonists in diabetic patients, likely due to improved glycemic control and reduced intraglomerular pressure
At 0.25 mg per week, that is 40 weeks of supply from a single vial